Bacteriophage infection drives loss of β-lactam resistance in methicillin-resistant Staphylococcus aureus

Curation statements for this article:
  • Curated by eLife

    eLife logo

    eLife Assessment

    The manuscript explores how bacterial evolution in the presence of lytic phages modulates b-lactams resistance and virulence properties in methicillin-resistant Staphylococcus aureus (MRSA). The work is useful as it identifies underlying mutations that may confer sensitivity to b-lactams and alter virulence properties. While the findings are generally convincing, additional experiments linking how particular mutations regulate phenotypic changes are required to improve the work mechanistically.

This article has been Reviewed by the following groups

Read the full article See related articles

Abstract

Bacteriophage (phage) therapy has been proposed as a means to combat drug-resistant bacterial pathogens. Infection by phage can select for mutations in bacterial populations that confer resistance against phage infection. However, resistance against phage can yield evolutionary trade-offs of biomedical use. Here we report the discovery of staphylococcal phages that cause different strains of methicillin-resistant Staphylococcus aureus (MRSA) to become sensitized to β-lactams, a class of antibiotics against which MRSA is typically highly resistant. MRSA cells that survive infection by these phages display significant reductions in minimal inhibitory concentration against different β-lactams compared to uninfected bacteria. Phage-treated MRSA further exhibited attenuated virulence phenotypes in the form of reduced hemolysis and clumping. Sequencing analysis revealed that the different MRSA strains evolved unique genetic profiles during infection. These results suggest complex evolutionary trajectories in MRSA during phage predation and open up new possibilities to reduce drug resistance and virulence in MRSA infections.

Article activity feed

  1. eLife Assessment

    The manuscript explores how bacterial evolution in the presence of lytic phages modulates b-lactams resistance and virulence properties in methicillin-resistant Staphylococcus aureus (MRSA). The work is useful as it identifies underlying mutations that may confer sensitivity to b-lactams and alter virulence properties. While the findings are generally convincing, additional experiments linking how particular mutations regulate phenotypic changes are required to improve the work mechanistically.

  2. Reviewer #1 (Public review):

    Summary:

    These authors have asked how lytic phage predation impacts antibiotic resistance and virulence phenotypes in methicillin-resistant Staphylococcus aureus (MRSA). They report that staphylococcal phages cause MRSA strains to become sensitized to b-lactams and to display reduced virulence. Moreover, they identify mutations in a set of genes required for phage infection that may impact antibiotic resistance and virulence phenotypes.

    Strengths:

    Phage-mediated re-sensitization to antibiotics has been reported previously but the underlying mutational analyses have not been described. These studies suggest that phages and antibiotics may target similar pathways in bacteria.

    Weaknesses:

    One limitation is the lack of mechanistic investigations linking particular mutations to the phenotypes reported here. This limits the impact of the work.

    Another limitation of this work is the use of lab strains and a single pair of phages. However, while incorporation of clinical isolates would increase the translational relevance of this work it is unlikely to change the conclusions.

  3. Reviewer #2 (Public review):

    Summary:

    The work presented in the manuscript by Tran et al deals with bacterial evolution in the presence of bacteriophage. Here, the authors have taken three methicillin-resistant S. aureus strains that are also resistant to beta-lactams. Eventually, upon being exposed to phage, these strains develop beta-lactam sensitivity. Besides this, the strains also show other changes in their phenotype such as reduced binding to fibrinogen and hemolysis.

    Strengths:

    The experiments carried out are convincing to suggest such in vitro development of sensitivity to the antibiotics. Authors were also able to "evolve" phage in a similar fashion thus showing enhanced virulence against the bacterium. In the end, authors carry out DNA sequencing of both evolved bacteria and phage and show mutations occurring in various genes. Overall, the experiments that have been carried out are convincing.

    Weaknesses:

    Although more experiments are not needed, additional experiments could add more information. For example, the phage gene showing the HTH motif could be reintroduced in the bacterial genome and such a strain can then be assayed with wildtype phage infection to see enhanced virulence as suggested. At least one such experiment proves the discoveries regarding the identification of mutations and their outcome. Secondly, I also feel that authors looked for beta-lactam sensitivity and they found it. I am sure that if they look for rifampicin resistance in these strains, they will find that too. In this case, I cannot say that the evolution was directed to beta-lactam sensitivity; this is perhaps just one trait that was observed. This is the only weakness I find in the work. Nevertheless, I find the experiments convincing enough; more experiments only add value to the work.